| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.09 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |